New insight into hedgehog signaling in hematological malignancies
- PMID: 24991722
- DOI: 10.3109/10428194.2014.938328
New insight into hedgehog signaling in hematological malignancies
Abstract
The hedgehog (Hh) signaling pathway is well established as being evolutionarily conserved across vertebrates, and is involved in organogenesis, hematopoiesis, embryogenesis and homeostasis of adult tissues. At a microscopic level, the Hh signaling pathway controls the proliferation, apoptosis, cell-cycle and differentiation programs of stem and progenitor cells. Increasing evidence suggests that aberrant activation of the Hh signaling pathway is related to neoplasm, including solid tumors and hematologic malignancies. Currently the Hh signaling pathway has become one of the most studied potential therapeutic targets in hematological malignancies. In this review, we focus on findings related to Hh signaling in the initiation, maintenance, progression and chemoresistance of hematological malignancies, looking forward to better targeted treatment strategies.
Keywords: Hedgehog signaling pathway; hematological malignancy; smoothened inhibitor; targeted therapy.
Similar articles
-
Aberrant activation of the hedgehog signaling pathway in malignant hematological neoplasms.Am J Pathol. 2012 Jan;180(1):2-11. doi: 10.1016/j.ajpath.2011.09.009. Epub 2011 Nov 1. Am J Pathol. 2012. PMID: 22056910 Free PMC article. Review.
-
Canonical and noncanonical Hedgehog/GLI signaling in hematological malignancies.Vitam Horm. 2012;88:25-54. doi: 10.1016/B978-0-12-394622-5.00002-X. Vitam Horm. 2012. PMID: 22391298 Review.
-
New prospects for drug development: the hedgehog pathway revealed. Focus on hematologic malignancies.Future Oncol. 2013 May;9(5):681-97. doi: 10.2217/fon.13.10. Future Oncol. 2013. PMID: 23647297 Review.
-
Molecular pathways: novel approaches for improved therapeutic targeting of Hedgehog signaling in cancer stem cells.Clin Cancer Res. 2015 Feb 1;21(3):505-13. doi: 10.1158/1078-0432.CCR-14-0507. Clin Cancer Res. 2015. PMID: 25646180 Free PMC article. Review.
-
Targeting hedgehog in hematologic malignancy.Blood. 2012 Mar 8;119(10):2196-204. doi: 10.1182/blood-2011-10-383752. Epub 2012 Jan 5. Blood. 2012. PMID: 22223823 Review.
Cited by
-
Opposite activation of the Hedgehog pathway in CD138+ plasma cells and CD138-CD19+ B cells identifies two subgroups of patients with multiple myeloma and different prognosis.Leukemia. 2016 Sep;30(9):1869-76. doi: 10.1038/leu.2016.77. Epub 2016 Apr 14. Leukemia. 2016. PMID: 27074969
-
Targeting glycogen synthase kinase 3 for therapeutic benefit in lymphoma.Blood. 2019 Jul 25;134(4):363-373. doi: 10.1182/blood.2018874560. Epub 2019 May 17. Blood. 2019. PMID: 31101621 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
